A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder
Author:
Affiliation:
1. Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder, Massachusetts General Hospital, Boston, MA, USA;
2. Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Publisher
Informa UK Limited
Subject
Biological Psychiatry,Psychiatry and Mental health
Link
https://www.tandfonline.com/doi/pdf/10.1080/15622975.2019.1679392
Reference39 articles.
1. Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder
2. Diagnostic and Statistical Manual of Mental Disorders
3. An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review of pharmacogenomics of psychiatric comorbidities in autism spectrum disorder;PHARMACOGENOMICS;2023
2. Pharmacological Interventions for Adults with Autism Spectrum Disorder;Handbook of Quality of Life for Individuals with Autism Spectrum Disorder;2022
3. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2021-08
4. Transition-Age Youth with Autism Spectrum Disorder;Transition-Age Youth Mental Health Care;2021
5. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature;Journal of Psychopharmacology;2020-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3